BlackRock’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.3M Sell
17,007,269
-165,759
-1% -$783K ﹤0.01% 2285
2025
Q4
$86.7M Buy
17,173,028
+625,335
+4% +$2.9M ﹤0.01% 2192
2025
Q3
$57.4M Sell
16,547,693
-487,842
-3% -$1.83M ﹤0.01% 2419
2025
Q2
$57.9M Sell
17,035,535
-1,033,747
-6% -$3.44M ﹤0.01% 2361
2025
Q1
$72.5M Sell
18,069,282
-413,513
-2% -$2.14M ﹤0.01% 2183
2024
Q4
$120M Sell
18,482,795
-9,496
-0.1% -$56.6K ﹤0.01% 1969
2024
Q3
$102M Buy
18,492,291
+1,421,869
+8% +$8.06M ﹤0.01% 2073
2024
Q2
$95.3M Sell
17,070,422
-355,549
-2% -$2.14M ﹤0.01% 2055
2024
Q1
$117M Sell
17,425,971
-353,782
-2% -$2.8M ﹤0.01% 1966
2023
Q4
$162M Buy
17,779,753
+1,009,080
+6% +$6.35M ﹤0.01% 1787
2023
Q3
$92.6M Buy
16,770,673
+1,643,168
+11% +$13.2M ﹤0.01% 2036
2023
Q2
$129M Buy
15,127,505
+6,840,258
+83% +$61.4M ﹤0.01% 1875
2023
Q1
$76.2M Sell
8,287,247
-80,360
-1% -$864K ﹤0.01% 2188
2022
Q4
$85.4M Buy
8,367,607
+449,965
+6% +$6.05M ﹤0.01% 2103
2022
Q3
$117M Buy
7,917,642
+780,250
+11% +$10.1M ﹤0.01% 1863
2022
Q2
$76.6M Buy
7,137,392
+1,044,052
+17% +$10.4M ﹤0.01% 2202
2022
Q1
$65.7M Buy
6,093,340
+3,722,881
+157% +$50.3M ﹤0.01% 2413
2021
Q4
$38.7M Buy
2,370,459
+515,716
+28% +$10.8M ﹤0.01% 2831
2021
Q3
$39.7M Buy
+1,854,743
New +$43.6M ﹤0.01% 2812

Other funds holding CTKB